ES2186596T1 - Uso de inhibidores de il-18. - Google Patents

Uso de inhibidores de il-18.

Info

Publication number
ES2186596T1
ES2186596T1 ES00944201T ES00944201T ES2186596T1 ES 2186596 T1 ES2186596 T1 ES 2186596T1 ES 00944201 T ES00944201 T ES 00944201T ES 00944201 T ES00944201 T ES 00944201T ES 2186596 T1 ES2186596 T1 ES 2186596T1
Authority
ES
Spain
Prior art keywords
inhibitors
medicaments
preparation
action
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES00944201T
Other languages
English (en)
Other versions
ES2186596T3 (es
Inventor
Charles Dinarello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Trading SA
Original Assignee
Ares Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SA filed Critical Ares Trading SA
Publication of ES2186596T1 publication Critical patent/ES2186596T1/es
Application granted granted Critical
Publication of ES2186596T3 publication Critical patent/ES2186596T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de inhibidores de la producción y/o acción de IL-18 en la preparación de medicamentos a fin de inhibir la metástasis de tumores.
ES00944201T 1999-07-22 2000-07-17 Uso de inhibidores de la interleucina-18 para inhibir metastasis tumorales. Expired - Lifetime ES2186596T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
IL131047 1999-07-22

Publications (2)

Publication Number Publication Date
ES2186596T1 true ES2186596T1 (es) 2003-05-16
ES2186596T3 ES2186596T3 (es) 2007-11-16

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00944201T Expired - Lifetime ES2186596T3 (es) 1999-07-22 2000-07-17 Uso de inhibidores de la interleucina-18 para inhibir metastasis tumorales.

Country Status (31)

Country Link
US (1) US7741276B2 (es)
EP (1) EP1206274B1 (es)
JP (1) JP4827352B2 (es)
KR (1) KR100682219B1 (es)
CN (1) CN1173736C (es)
AR (1) AR024907A1 (es)
AT (1) ATE363288T1 (es)
AU (1) AU782478B2 (es)
BG (1) BG65800B1 (es)
BR (1) BR0012675A (es)
CA (1) CA2380216C (es)
CY (1) CY1107932T1 (es)
CZ (1) CZ302114B6 (es)
DE (2) DE60035049T2 (es)
DK (1) DK1206274T3 (es)
EA (1) EA005419B1 (es)
EE (1) EE04838B1 (es)
ES (1) ES2186596T3 (es)
HK (1) HK1048248B (es)
HU (1) HU228780B1 (es)
IL (2) IL131047A0 (es)
MX (1) MXPA02000838A (es)
NO (1) NO329827B1 (es)
NZ (1) NZ516535A (es)
PL (1) PL202477B1 (es)
PT (1) PT1206274E (es)
SK (1) SK287522B6 (es)
TR (1) TR200200169T2 (es)
UA (1) UA73745C2 (es)
WO (1) WO2001007480A2 (es)
ZA (1) ZA200200390B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK12942002A3 (sk) 2000-02-10 2003-05-02 Abbott Laboratories Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia
AU2002211744B8 (en) 2000-10-11 2008-03-20 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
BR0210904A (pt) * 2001-05-16 2005-08-16 Yeda Res & Dev Uso de inibidores de il-18 para o tratamento ou prevenção de sepse
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
BR0315155A (pt) * 2002-10-08 2005-08-16 Ares Trading Sa Uso de citocina capaz de ligar il-18bp e de inibir a atividade de uma segunda citocina
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
CA2609060C (en) 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
CA3259975A1 (en) 2022-03-15 2023-09-21 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
EP4646433A1 (en) 2023-01-06 2025-11-12 Lassen Therapeutics, Inc. Anti-il-18bp antibodies
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ299210A (en) * 1992-09-02 2000-08-25 Isis Pharmaceuticals Inc Treating diseases characterised by changes in intercellular adhesion molecules using coding sequences hybridizable with those encoding proteins involved in synthesis of such molecules
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
BRPI0012675B1 (pt) 2001-02-01
HU228780B1 (en) 2013-05-28
BRPI0012675B8 (es) 2021-05-25
DE60035049T2 (de) 2007-09-27
IL147675A (en) 2009-05-04
AR024907A1 (es) 2002-10-30
KR20020027493A (ko) 2002-04-13
HUP0202107A2 (en) 2002-10-28
EA200200189A1 (ru) 2002-12-26
CZ2002195A3 (cs) 2002-06-12
CN1364086A (zh) 2002-08-14
NO20020153L (no) 2002-03-11
DK1206274T3 (da) 2007-08-13
JP4827352B2 (ja) 2011-11-30
NO329827B1 (no) 2011-01-03
PT1206274E (pt) 2007-07-06
NZ516535A (en) 2004-04-30
CN1173736C (zh) 2004-11-03
TR200200169T2 (tr) 2002-06-21
HK1048248A1 (en) 2003-03-28
HK1048248B (zh) 2005-04-22
JP2003505472A (ja) 2003-02-12
UA73745C2 (en) 2005-09-15
US20080003216A1 (en) 2008-01-03
ES2186596T3 (es) 2007-11-16
SK287522B6 (sk) 2011-01-04
PL202477B1 (pl) 2009-06-30
CZ302114B6 (cs) 2010-10-20
AU782478B2 (en) 2005-08-04
WO2001007480A2 (en) 2001-02-01
BG65800B1 (bg) 2009-12-31
EE04838B1 (et) 2007-06-15
ATE363288T1 (de) 2007-06-15
HUP0202107A3 (en) 2005-01-28
EP1206274A2 (en) 2002-05-22
AU5843200A (en) 2001-02-13
BG106311A (en) 2002-08-30
EP1206274B1 (en) 2007-05-30
CY1107932T1 (el) 2013-09-04
EE200200032A (et) 2003-02-17
IL131047A0 (en) 2001-01-28
SK882002A3 (en) 2002-07-02
MXPA02000838A (es) 2002-07-30
CA2380216A1 (en) 2001-02-01
KR100682219B1 (ko) 2007-02-12
CA2380216C (en) 2012-01-31
NO20020153D0 (no) 2002-01-11
EA005419B1 (ru) 2005-02-24
DE60035049D1 (de) 2007-07-12
BR0012675A (pt) 2002-04-09
ZA200200390B (en) 2003-04-30
PL353732A1 (en) 2003-12-01
WO2001007480A3 (en) 2001-05-10
US7741276B2 (en) 2010-06-22
DE1206274T1 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
PT1193270E (pt) Pirrolobenzodiazepinas
CA99345S (en) Container
DE60139401D1 (de) Erweiterung des bereichs rechnerischer körper von ganzen zahlen
PL343466A1 (en) Substituted benzamides, their production and their use as cysteine protease inhibitors
ID30590A (id) Celana sekali pakai jenis-celana pendek
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
EE200200626A (et) Antraniilamiidid ja nende kasutamine ravimitena
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
NO20025758L (no) Anvendelse av skrueviklet rörkonstruksjon i brönnmiljöet
ID30116A (id) Turunan-turunan piridopiranoazepin, pembuatannya dan penggunaan terapinya
IT250013Y1 (it) Struttura di supporto di oggetti in genere
NO20024806D0 (no) Apomorfinderivater samt anvendelse derav
DE60121079D1 (de) Minderung des Streifeneffektes in schrittweisem Druck
BR9912327A (pt) Inibidores da uroquinase
CA96874S (en) Set of flatware
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
PL366397A1 (pl) Zastosowanie szczepów owczego parapoksywirusa do wytwarzania przeciwwirusowych i przeciwnowotworowych środków farmaceutycznych
FI20010620L (fi) Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa
DK1330244T3 (da) Præparater der omfatter modafinilforbindelser
DE60125981D1 (de) Amlodipin in form der freien base
IS6381A (is) Nýjung við notkun mótefna í bóluefni
CA96875S (en) Set of flatware
DE60230785D1 (de) Polymorphe marker die benutzt werden kann, um die wirksamkeit der interferon-therapie festzustellen
SE9904749D0 (sv) Polycrystalline diamond microstructures
TR199801669A3 (tr) Sodyum-hidrojen degisim inhibitörlerinin bir ilaç üretiminde kullanimi.